Dong Xu Qiu
Founder chez CANSINO BIOLOGICS INC.
Profil
Dong Xu Qiu a fondé CanSino Biologics, Inc. Il est membre du conseil d'administration de CanSino Biologics, Inc. et conseiller principal chez ChinaBio LLC. Le Dr Qiu a obtenu un doctorat de l'Université de Pékin, un MBA de l'Université de Western Ontario, un diplôme de premier cycle de l'Université pharmaceutique de Shenyang, un doctorat de l'Université de Constance et un doctorat de l'Université de Montréal.
Postes actifs de Dong Xu Qiu
| Sociétés | Poste | Début |
|---|---|---|
| CANSINO BIOLOGICS INC. | Founder | 13/01/2009 |
Suzhou GenePharma Co., Ltd.
 Suzhou GenePharma Co., Ltd. BiotechnologyHealth Technology Suzhou GenePharma Co.,Ltd. engages in the manufacture of biotechnology products. Its products cover chemically-synthetic RNA monomer, RNA oligo synthesis, and the relevant modifiers, labeling, and fluorescein reagents. The company was founded on August 27, 2007 and is headquartered in Shanghai, China. | Director/Board Member | - |
Anciens postes connus de Dong Xu Qiu
| Sociétés | Poste | Fin |
|---|---|---|
ChinaBio LLC
 ChinaBio LLC Financial ConglomeratesFinance ChinaBio LLC operates as an investment, consulting and media company which helps life science companies. It organizes life science investment and partnering conferences in China. The firm’s conferences comprise investor forums, partnering forums, executive workshops and SEED business plan competitions. It also offers consulting services, including China strategy development, market and competitive intelligence, technology survey and search, partnering arrangement, CRO and CMO selection, management, business strategy, funding strategy, assistance, collaboration agreements, in-licensing, out-licensing, the United States operations consulting services, investment analysis, due diligence and portfolio analysis. The company serves executives, entrepreneurs, investors, pharma and multinational companies. ChinaBio was founded in April 2007 by Greg B. Scott and James W. Larrick and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/04/2011 |
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01/01/2002 |
Formation de Dong Xu Qiu
| Peking University | Doctorate Degree |
| University of Western Ontario | Masters Business Admin |
| University of Montréal | Doctorate Degree |
| Universität Konstanz | Doctorate Degree |
| Shenyang Pharmaceutical University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CANSINO BIOLOGICS INC. | Health Technology |
 | Health Technology |
| Entreprise privées | 2 |
|---|---|
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Health Technology |
ChinaBio LLC
ChinaBio LLC Financial ConglomeratesFinance ChinaBio LLC operates as an investment, consulting and media company which helps life science companies. It organizes life science investment and partnering conferences in China. The firm’s conferences comprise investor forums, partnering forums, executive workshops and SEED business plan competitions. It also offers consulting services, including China strategy development, market and competitive intelligence, technology survey and search, partnering arrangement, CRO and CMO selection, management, business strategy, funding strategy, assistance, collaboration agreements, in-licensing, out-licensing, the United States operations consulting services, investment analysis, due diligence and portfolio analysis. The company serves executives, entrepreneurs, investors, pharma and multinational companies. ChinaBio was founded in April 2007 by Greg B. Scott and James W. Larrick and is headquartered in Shanghai, China. | Finance |
